Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'mdma properties' OR with Authors including 'mdma properties' OR with Abstract including 'mdma properties' OR with Keywords including 'mdma properties'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Beck J, Morgan PA Designer drug confusion: a focus on MDMA J Drug Educ 1986
Schechter MD Discriminative profile of MDMA Pharmacol Biochem Be... 1986
Buchanan JF, Brown CR 'Designer drugs'. A problem in clinical toxicology Med Toxicol Adverse ... 1988
Callahan PM, Appel JB Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... J Pharmacol Exp Ther 1988
Gold LH, Koob GF Methysergide potentiates the hyperactivity produced by MDMA in rats Pharmacol Biochem Be... 1988
Mamounas LA, Molliver ME Evidence for dual serotonergic projections to neocortex: axons from th... Exp Neurol 1988
Oberlender R, Nichols DE Drug discrimination studies with MDMA and amphetamine Psychopharmacology (... 1988
Peroutka SJ, Newman H, Ha... Subjective effects of 3,4-methylenedioxymethamphetamine in recreationa... Neuropsychopharmacol... 1988
Schechter MD Use of TFMPP stimulus properties as a model of 5-HT1B receptor activat... Pharmacol Biochem Be... 1988
Schechter MD Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetami... Pharmacol Biochem Be... 1989
Gold LH, Geyer MA, Koob G... Psychostimulant properties of MDMA NIDA Res Monogr 1989
Gold LH, Geyer MA, Koob G... Neurochemical mechanisms involved in behavioral effects of amphetamine... NIDA Res Monogr 1989
Gold LH, Hubner CB, Koob ... A role for the mesolimbic dopamine system in the psychostimulant actio... Psychopharmacology (... 1989
Gold LH, Koob GF MDMA produces stimulant-like conditioned locomotor activity Psychopharmacology (... 1989
Nichols DE, Oberlender R Structure-activity relationships of MDMA-like substances NIDA Res Monogr 1989
Peroutka SJ 'Ecstasy': a human neurotoxin? Arch Gen Psychiatry 1989
Callaway CW, Wing LL, Gey... Serotonin release contributes to the locomotor stimulant effects of 3,... J Pharmacol Exp Ther 1990
De Souza EB, Battaglia G,... Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... Ann N Y Acad Sci 1990
Evans SM, Zacny JP, Johan... Three-choice discrimination among (+)-amphetamine, fenfluramine and sa... Pharmacol Biochem Be... 1990
Gibb JW, Johnson M, Hanso... Neurochemical basis of neurotoxicity Neurotoxicology 1990
Hekmatpanah CR, Peroutka ... 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-... Eur J Pharmacol 1990
Nichols DE, Oberlender R Structure-activity relationships of MDMA and related compounds: a new ... Ann N Y Acad Sci 1990
Oberlender R, Nichols DE (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... J Pharmacol Exp Ther 1990
Teitler M, Leonhardt S, A... Receptor pharmacology of MDMA and related hallucinogens Ann N Y Acad Sci 1990
McKenna DJ, Guan XM, Shul... 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... Pharmacol Biochem Be... 1991
Bilsky EJ, Hubbell CL, De... MDMA produces a conditioned place preference and elicits ejaculation i... Pharmacol Biochem Be... 1991
Garrett ER, Seyda K, Marr... High performance liquid chromatographic assays of the illicit designer... Acta Pharm Nord 1991
Johnson MP, Conarty PF, N... [3H]monoamine releasing and uptake inhibition properties of 3,4-methyl... Eur J Pharmacol 1991
Paulus MP, Geyer MA A temporal and spatial scaling hypothesis for the behavioral effects o... Psychopharmacology (... 1991
Schifano F Chronic atypical psychosis associated with MDMA ('ecstasy') abuse Lancet 1991
Gouzoulis E, Steiger A, E... Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in ... Biol Psychiatry 1992
Callaway CW, Geyer MA Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus ... Eur J Pharmacol 1992
Herndon JL, Pierson ME, G... Mechanistic investigation of the stimulus properties of 1-(3-trifluoro... Pharmacol Biochem Be... 1992
Johnson M, Elayan I, Hans... Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... J Pharmacol Exp Ther 1992
Kehne JH, McCloskey TC, T... Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (... J Pharmacol Exp Ther 1992
Solowij N, Hall W, Lee N Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and thei... Br J Addict 1992
Zhao ZY, Castagnoli N Jr,... Synthesis and neurotoxicological evaluation of putative metabolites of... Chem Res Toxicol 1992
Heilig, Steve MDMA Update: The Science and Politics of Ecstasy Newsletter of the Ca... 1993
Stolaroff MJ, Wells CW Preliminary Results with New Psychoactive Agents 2C-T-2 AND 2C-T-7 Yearbook for Ethnome... 1993
Krebs KM, Geyer MA Behavioral characterization of alpha-ethyltryptamine, a tryptamine der... Psychopharmacology (... 1993
Robinson TE, Castaneda E,... Effects of cortical serotonin depletion induced by 3,4-methylenedioxym... Neuropsychopharmacol... 1993
Schechter MD, Gordon TL Comparison of the behavioral effects of ibogaine from three sources: m... Eur J Pharmacol 1993
Schuldiner S, Steiner-Mor... Amphetamine Derivatives Interact with Both Plasma Membrane and Secreto... Mol Pharmacol 1993
McDowell DM, Kleber HD MDMA: Its history and pharmacology Psychiatric Annals 1994
Bronson ME, Barrios-Zambr... Behavioral and developmental effects of two 3,4-methylenedioxymethamph... Drug Alcohol Depend 1994
Leonardi ETK, Azmitia EC MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with f... Neuropsychopharmacol... 1994
Marona-Lewicka D, Nichols... Behavioral effects of the highly selective serotonin releasing agent 5... Eur J Pharmacol 1994
Miller DB, O'Callaghan JP The role of temperature, stress, and other factors in the neurotoxicit... Mol Neurobiol 1995
Premkumar LS, Ahern GP Blockade of a resting potassium channel and modulation of synaptic tra... J Pharmacol Exp Ther 1995
Obradovic T, Imel KM, Whi... Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... Neuroscience 1996
Marona-Lewicka D, Rhee GS... Reinforcing effects of certain serotonin-releasing amphetamine derivat... Pharmacol Biochem Be... 1996
Miller DB, O'Callaghan JP Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Interac... Ann N Y Acad Sci 1996
Obradovic T, Imel KM, Whi... Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... Neuroscience 1996
Lin HQ, Jackson DM, Atren... Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-el... Brain Res 1997
Crespi D, Mennini T, Gobb... Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induc... Br J Pharmacol 1997
Taraska T, Finnegan KT Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-met... J Pharmacol Exp Ther 1997
Schwartz RH, Miller NS MDMA (ecstasy) and the rave: a review Pediatrics 1997
Baker LE, Taylor MM Assessment of the MDA and MDMA optical isomers in a stimulant-hallucin... Pharmacol Biochem Be... 1997
Glennon RA, Young R, Duka... Initial characterization of PMMA as a discriminative stimulus Pharmacol Biochem Be... 1997
Schechter MD Serotonergic mediation of fenfluramine discriminative stimuli in fawn-... Life Sci 1997
Zheng Y, Laverty R Role of brain nitric oxide in (+/-)3,4-methylenedioxymethamphetamine (... Brain Res 1998
Connor TJ, McNamara MG, F... Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces ... Immunopharmacology 1998
Bilsky EJ, Montegut MJ, N... CGS 10746B, a novel dopamine release inhibitor, blocks the establishme... Pharmacol Biochem Be... 1998
Jansen KL, Forrest AR Toxic effect of MDMA on brain serotonin neurons Lancet 1999
Hamilton J, Balint P, Fie... A concealed cause of recurrent renal failure in a patient with juvenil... Ann Rheum Dis 1999
Laviola G, Adriani W, Ter... Psychobiological risk factors for vulnerability to psychostimulants in... Neurosci Biobehav Re... 1999
Lin HQ, Burden PM, Christ... The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the... Pharmacol Biochem Be... 1999
Pacifici R, Zuccaro P, Fa... Immunomodulating properties of MDMA alone and in combination with alco... Life Sci 1999
van Aerts LAGJM, Malleret... N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties ... Addiction Biology 2000
Aalberg L, DeRuiter J, No... Chromatographic and Mass Spectral Methods of Identification for the Si... J Chromatogr Sci 2000
Cami J, Farre M, et al Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'): p... J Clin Psychopharmac... 2000
Johnson EA, Sharp DS, Mil... Restraint as a stressor in mice: against the dopaminergic neurotoxicit... Brain Res 2000
Maldonado E, Navarro JF Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mic... Prog Neuropsychophar... 2000
Sharma R, Nelson LS Methylenedioxymethamphetamine (MDMA) induced hyponatremia Int J Med Toxicol 2000
Connor TJ, Dennedy MC, Ha... Methylenedioxymethamphetamine-induced suppression of interleukin-1beta... Eur J Pharmacol 2001
Maldonado E, Navarro JF Mdma (‘ecstasy’) exhibits an anxiogenic-like activity in social encoun... Pharmacological Rese... 2001
Kalant, H The pharmacology and toxicology of 'ecstasy' (MDMA) and related drugs Canadian Medical Ass... 2001
Logan BK, Couper FJ 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairme... J Forensic Sci 2001
Teter CJ, Guthrie SK A comprehensive review of MDMA and GHB: two common club drugs Pharmacotherapy 2001
Leshner AI What should the public be told about the risks of Ecstasy? JAMA 2002
Glennon RA, Young R, Rang... Further characterization of the stimulus properties of 5,6,7,8- tetrah... Pharmacol Biochem Be... 2002
Szabo Z, McCann UD, Wilso... Comparison of (+)-(11)C-McN5652 and (11)C-DASB as Serotonin Transporte... J Nucl Med 2002
Anonymous Ecstasy [a brief introduction] Psychiatric Services... 2002
Gobbi M, Moia M, Pirona L... p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neur... J Neurochem 2002
Jiang XR, Dryhurst G Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehyd... Chem Res Toxicol 2002
Kelly PA, Ritchie IM, Qua... Functional consequences of perinatal exposure to 3,4-methylenedioxymet... Br J Pharmacol 2002
Riba J, Rodri­guez-Fornel... Effects of ayahuasca on sensory and sensorimotor gating in humans as m... Psychopharmacology (... 2002
Pizarro N, Llebaria A, Ca... Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its m... Rapid Commun Mass Sp... 2003
Cole JC, Sumnall HR, O'Sh... Effects of MDMA exposure on the conditioned place preference produced ... Psychopharmacology (... 2003
Goodwin AK, Pynnonen DM, ... Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus ... Pharmacol Biochem Be... 2003
Mlinar B, Corradetti R Endogenous 5-HT, released by MDMA through serotonin transporter- and s... Eur J Neurosci 2003
Salzmann J, Marie-Claire ... Importance of ERK activation in behavioral and biochemical effects ind... Br J Pharmacol 2003
de la Torre R, Farre M, R... Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposit... Ther Drug Monit 2004
Bubar MJ, Pack KM, Franke... Effects of dopamine D(1)- or D(2)-like receptor antagonists on the hyp... Psychopharmacology (... 2004
Johnson EA, O\'Callaghan ... Brain concentrations of d-MDMA are increased after stress Psychopharmacology (... 2004
Pizarro N, Farre M, Pujad... Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its m... Drug Metab Dispos 2004
Sala M, Braida D Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interact... Pharmacol Biochem Be... 2005
Kehr J, Ichinose F, Yoshi... Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increa... Br J Pharmacol 2011
Parrott AC Residual neurocognitive features of ecstasy use: a re-interpretation o... Addiction 2011
Hill SL, Thomas SH Clinical toxicology of newer recreational drugs Clin Toxicol (Phila) 2011

Page 1 of 2   /   109 Entries Returned
2 next